Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Permian Resources | PR | Dec 26, 2024 | 13.87 | -0.57 |
Permianville Royalty Trust Unit | PVL | Dec 26, 2024 | 1.36 | +1.88 |
PermRock Royalty Trust Unit | PRT | Dec 26, 2024 | 3.67 | +0.82 |
Perpetua Resources | PPTA | Dec 26, 2024 | 11.21 | -2.27 |
Perrigo | PRGO | Dec 26, 2024 | 26.01 | +1.44 |
Personalis | PSNL | Dec 26, 2024 | 6.26 | +2.79 |
Perspective Therapeutics | CATX | Dec 26, 2024 | 3.29 | +1.23 |
Petco Health And Wellness | WOOF | Dec 26, 2024 | 4.13 | +4.56 |
PetMed Express | PETS | Dec 26, 2024 | 5.26 | +3.75 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Dec 26, 2024 | 13.09 | +0.46 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Dec 26, 2024 | 12.03 | -0.25 |
Petros Pharmaceuticals | PTPI | Dec 26, 2024 | 0.31 | +7.88 |
Pfizer | PFE | Dec 26, 2024 | 26.56 | -0.67 |
PG&E Pref A | PCG-X | Dec 26, 2024 | 49.86 | 0.00 |
Pgim Global High Yield Fund | GHY | Dec 26, 2024 | 12.53 | -0.79 |
Pgim High Yield Bond Fund | ISD | Dec 26, 2024 | 13.84 | -0.65 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Dec 26, 2024 | 16.23 | -0.55 |
Pharmaceutical ETF Market Vectors | PPH | Dec 26, 2024 | 87.85 | +0.17 |
PharmaCyte Biotech | PMCB | Dec 26, 2024 | 1.56 | -2.50 |
Pharming Group ADR | PHAR | Dec 26, 2024 | 10.60 | +0.47 |
Pharvaris | PHVS | Dec 26, 2024 | 19.50 | +3.56 |
Phathom Pharmaceuticals | PHAT | Dec 26, 2024 | 8.10 | +8.00 |
PhenixFIN | PFX | Dec 26, 2024 | 51.00 | 0.00 |
Pheton | PTHL | Dec 26, 2024 | 4.15 | +7.79 |
Phibro Animal Health A | PAHC | Dec 26, 2024 | 21.68 | +0.18 |
Philip Morris | PM | Dec 26, 2024 | 121.71 | -0.98 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Dec 26, 2024 | 25.27 | +1.32 |
Phillips 66 | PSX | Dec 26, 2024 | 112.20 | +0.56 |
Phillips Edison & Company | PECO | Dec 26, 2024 | 38.52 | +0.78 |
PHINIA | PHIN | Dec 26, 2024 | 48.66 | +1.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.